News | News By Subject | News by Disease News By Date | Search News

Skin infection News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
AstraZeneca PLC (AZN) Gets Closer to a Decision on Suicide-Linked Drug, CEO Says     6/3/2015
arGEN-X, LEO Pharma Forge $116 Million Skin Pact     5/22/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
Woman Alleges Pfizer (PFE) Drug Left Her In Wheelchair     8/4/2014
FDA Approves Durata Therapeutics, Inc.  (DRTX)'s Dalvance To Treat Skin Infections     5/28/2014
Provectus Biopharmaceuticals Inc.: Short-Term Catalysts And Positive Trial Results Could Help Shares     5/13/2014
FDA Panel Backs Durata Therapeutics, Inc.  (DRTX)'s Two New Anti-Infective Drugs     4/1/2014
Novartis AG (NVS)'s Omalizumab Shines in Third Phase 3 Hives Trial     10/8/2013
Pfizer Inc. (PFE)'s Cancer Drug Sutent Linked to Severe Skin Reactions     9/10/2013
Galderma Laboratories Receives FDA Approval of Mirvaso®: the First and Only FDA-Approved Topical Treatment Specifically Developed and Indicated for the Facial Erythema of Rosacea     8/26/2013
Trius Therapeutics (TSRX)'s Tedizolid Meets Endpoint in Ph3     3/25/2013
Roche (RHHBY)'s Rituxan Cures Rare Skin-Blistering Disease in Study     3/8/2013
Durata Therapeutics, Inc.  (DRTX) Says Skin Infection Drug Meets Late-Stage Trial Goal     1/4/2013
Nuvo Research Inc. (NRI.TO) and Galderma Pharma S.A. Announce FDA Approval of Pliaglis     10/22/2012

News from Around the Web
Nasal Bacteria May Be Predictor Of Skin Infections, Uniformed Services University Of The Health Sciences Study     5/22/2014
Researchers Demonstrate Mechanism Behind Compound’s Effects on Skin Inflammation and Cancer Progression, Brigham and Women's Hospital Study     5/24/2011
An Infestation that Begins in the Mind, Mayo Clinic Study     5/17/2011
Sildenafil Reduces Raynaud's Frequency in Patients with Systemic Sclerosis, Study Published in Arthritis & Rheumatism     3/9/2011
Cephalexin Useful in Pediatric MRSA, Johns Hopkins University School of Medicine Study     2/22/2011
FDA Weighs Skin Risks of Bayer AG (BAY.F) Imaging Drug     1/19/2011
Propranolol Bests Prednisone for Treating Hemangiomas, University Of Montreal Study     11/11/2010
Houston, They Had a Problem: How NASA Doctors Helped in Chile     11/9/2010
Molecular Switch Controls Melanin Production, May Allow True Sunless Tanning, Massachusetts General Hospital Study     10/15/2010
Afamelanotide Implants Effective For Erythropoietic Protoporphyria, Triemli Hospital Study     10/14/2010
Stem Cell Treatment May Offer Hope Against Fatal Skin Disorder, University of Minnesota Study     8/12/2010
Scientists Unravel Causes of Mysterious Skin Disease, University of Florida Study     6/7/2010
Pumpkin Skin May Scare Away Germs, American Chemical Society     10/29/2009
British Association of Dermatologists Doctors Warn Of Rash From Mobile Phone Use     10/17/2008
Oral Vitamin D May Help Prevent Some Skin Infections, University of California, San Diego (UCSD) School Of Medicine Study     10/7/2008

Press Releases
Paratek Pharma (PRTK)'s Antibiotic Meets All Endpoints in Late-Stage Study     7/18/2017
Dermira (DERM) Release: Newly Published Nonclinical Data Highlight The Role Of Olumacostat Glasaretil In Sebum Inhibition     6/26/2017
New Microbiology Data Reinforce Activity Of Paratek Pharma (PRTK)’s Omadacycline Against Pathogens Of Importance In Respiratory, Skin And Urinary Tract Infections     6/5/2017
Novan Presents Preclinical Data From Inflammatory Skin Diseases Program     4/27/2017
Aclaris (ACRS) Submits New Drug Application For A-101 As A Novel Treatment For Seborrheic Keratosis – A Common Skin Condition     2/27/2017
Aclaris (ACRS) Announces Positive Top-Line Phase III Results For A-101 In Treating Seborrheic Keratosis, A Common Undertreated Skin Condition     11/16/2016
Aclaris (ACRS) Release: New Observational Study Demonstrates Patient Impact Of Seborrheic Keratosis, A Common, Undertreated Skin Condition Affecting 83.8 Million Americans     10/19/2016
Galderma Laboratories Announces Availability Of New Mirvaso (Brimonidine) Topical Gel, 0.33%* Pump Dispenser For The Treatment Of The Persistent Facial Redness Of Rosacea     5/19/2016
Melinta's Baxdela Successfully Achieves Primary Endpoints in Late Stage Study     5/12/2016
Fibrocell Science, Inc. And Intrexon Announce Allowance To Commence Phase I/II Trial For FCX-007 For The Treatment Of Recessive Dystrophic Epidermolysis Bullosa (RDEB)     4/18/2016
Cytori Therapeutics (CYTX) Update On Its U.S. Phase III Scleroderma Trial     3/24/2016
Avita Medical Wins FDA Approval for Increase in Compassionate Use of ReCell Patient Cases     3/7/2016
Cempra Doses First Patient In Phase III Clinical Trial Of Taksta In Acute Bacterial Skin And Skin Structure Infections     12/8/2015
TetraLogic Pharmaceuticals (TLOG) Announces The Opening Of An IND For SHAPE Gel In Alopecia Areata     11/2/2015
Foamix Pharmaceuticals, Ltd. (FOMX) Announces Enrollment Of First Patient In Phase II Clinical Trial Of FMX103 In Papulopustular Rosacea     10/20/2015